Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/21169159/ below:

Development and evaluation of the personal patient profile-prostate (P3P), a Web-based decision support system for men newly diagnosed with localized prostate cancer

Affiliations

• ¹ Dana-Farber Cancer Institute, Boston, United States. donna_berry@dfci.harvard.edu

• PMID: 21169159
• PMCID: PMC3056527
• DOI: 10.2196/jmir.1576

Item in Clipboard

Donna L Berry et al. J Med Internet Res. 2010.

• ¹ Dana-Farber Cancer Institute, Boston, United States. donna_berry@dfci.harvard.edu

• PMID: 21169159
• PMCID: PMC3056527
• DOI: 10.2196/jmir.1576

Item in Clipboard

Background: Given that no other disease with the high incidence of localized prostate cancer (LPC) has so many treatments with so few certainties related to outcomes, many men are faced with assuming some responsibility for the treatment decision along with guidance from clinicians. Men strongly consider their own personal characteristics and other personal factors as important and influential to the decision. Clinical researchers have not developed or comprehensively investigated interventions to facilitate the insight and prioritizing of personal factors along with medical factors that are required of a man in preparation for the treatment decision.

Objectives: The purpose of this pilot study was to develop and evaluate the feasibility and usability of a Web-based decision support technology, the Personal Patient Profile-Prostate (P3P), in men newly diagnosed with LPC.

Methods: Use cases were developed followed by infrastructure and content application. The program was provided on a personal desktop computer with a touch screen monitor. Participant responses to the query component of P3P determined the content of the multimedia educational and coaching intervention. The intervention was tailored to race, age, and personal factors reported as influencing the decision. Prepilot usability testing was conducted using a "think aloud" interview to identify navigation and content challenges. These issues were addressed prior to deployment in the clinic. A clinical pilot was conducted in an academic medical center where men sought consultation and treatment for LPC. Completion time, missing data, and acceptability were measured.

Results: Prepilot testing included 4 men with a past diagnosis of LPC who had completed therapy. Technical navigation issues were documented along with confusing content language. A total of 30 additional men with a recent diagnosis of LPC completed the P3P program in clinic prior to consulting with a urologist regarding treatment options. In a mean time of 46 minutes (SD 13 minutes), participants completed the P3P query and intervention components. Of a possible 4560 items for 30 participants, 22 (0.5%) were missing. Acceptability was reported as high overall. The sections of the intervention reported as most useful were the statistics graphs, priority information topics, and annotated external website links.

Conclusions: The P3P intervention is a feasible and usable program to facilitate treatment decision making by men with newly diagnosed LPC. Testing in a multisite randomized trial with a diverse sample is warranted.

PubMed Disclaimer

None declared

Clinical and application flow

Clinical and application flow

Clinical and application flow

• Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer.

  Bosco JL, Halpenny B, Berry DL. Bosco JL, et al. Health Qual Life Outcomes. 2012 Sep 28;10:123. doi: 10.1186/1477-7525-10-123. Health Qual Life Outcomes. 2012. PMID: 23021156 Free PMC article. Clinical Trial.

• The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: a multi-center randomized trial.

  Berry DL, Halpenny B, Hong F, Wolpin S, Lober WB, Russell KJ, Ellis WJ, Govindarajulu U, Bosco J, Davison BJ, Bennett G, Terris MK, Barsevick A, Lin DW, Yang CC, Swanson G. Berry DL, et al. Urol Oncol. 2013 Oct;31(7):1012-21. doi: 10.1016/j.urolonc.2011.10.004. Epub 2011 Dec 7. Urol Oncol. 2013. PMID: 22153756 Free PMC article. Clinical Trial.

• Assigning value to preparation for prostate cancer decision making: a willingness to pay analysis.

  Wilson LS, Blonquist TM, Hong F, Halpenny B, Wolpin S, Chang P, Filson CP, Master VA, Sanda MG, Chien GW, Jones RA, Krupski TL, Berry DL. Wilson LS, et al. BMC Med Inform Decis Mak. 2019 Jan 9;19(1):6. doi: 10.1186/s12911-018-0725-4. BMC Med Inform Decis Mak. 2019. PMID: 30626400 Free PMC article. Clinical Trial.

• Examining the effectiveness and implementation of patient treatment decision-aid tools for men with localised prostate cancer: A systematic review.

  Todio E, Sharp J, Morrow A, Taylor N, Schofield P, Mazariego C. Todio E, et al. Psychooncology. 2023 Apr;32(4):469-491. doi: 10.1002/pon.6094. Epub 2023 Jan 27. Psychooncology. 2023. PMID: 36610001 Review.

• [Treatment of nonmetastatic prostate cancer: a systematic review of interactive, personalized patient decision aids].

  Groeben C, Streuli JC, Krones T, Keck B, Wirth MP, Huber J. Groeben C, et al. Urologe A. 2014 Jun;53(6):854-64. doi: 10.1007/s00120-014-3529-x. Urologe A. 2014. PMID: 24903837 Review. German.

• Adoption, Acceptability, and Effectiveness of a Mobile Health App for Personalized Prostate Cancer Survivorship Care: Protocol for a Realist Case Study of the Ned App.

  Pham Q, Cafazzo JA, Feifer A. Pham Q, et al. JMIR Res Protoc. 2017 Oct 12;6(10):e197. doi: 10.2196/resprot.8051. JMIR Res Protoc. 2017. PMID: 29025699 Free PMC article.

• Decision preparation, satisfaction and regret in a multi-center sample of men with newly diagnosed localized prostate cancer.

  Berry DL, Wang Q, Halpenny B, Hong F. Berry DL, et al. Patient Educ Couns. 2012 Aug;88(2):262-7. doi: 10.1016/j.pec.2012.04.002. Epub 2012 May 17. Patient Educ Couns. 2012. PMID: 22608696 Free PMC article. Clinical Trial.

• Are cancer-related decision aids appropriate for socially disadvantaged patients? A systematic review of US randomized controlled trials.

  Enard KR, Dolan Mullen P, Kamath GR, Dixon NM, Volk RJ. Enard KR, et al. BMC Med Inform Decis Mak. 2016 Jun 6;16:64. doi: 10.1186/s12911-016-0303-6. BMC Med Inform Decis Mak. 2016. PMID: 27267490 Free PMC article.

• Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial.

  Berry DL, Hong F, Blonquist TM, Halpenny B, Filson CP, Master VA, Sanda MG, Chang P, Chien GW, Jones RA, Krupski TL, Wolpin S, Wilson L, Hayes JH, Trinh QD, Sokoloff M, Somayaji P. Berry DL, et al. J Urol. 2018 Jan;199(1):89-97. doi: 10.1016/j.juro.2017.07.076. Epub 2017 Jul 25. J Urol. 2018. PMID: 28754540 Free PMC article. Clinical Trial.

• Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial.

  Berry DL, Hong F, Blonquist TM, Halpenny B, Xiong N, Filson CP, Master VA, Sanda MG, Chang P, Chien GW, Jones RA, Krupski TL, Wolpin S, Wilson L, Hayes JH, Trinh QD, Sokoloff M. Berry DL, et al. Urol Oncol. 2021 Aug;39(8):493.e9-493.e15. doi: 10.1016/j.urolonc.2020.11.038. Epub 2021 Jan 19. Urol Oncol. 2021. PMID: 33353864 Free PMC article. Clinical Trial.

1. 1. Berry DL, Ellis WJ, Woods NF, Schwien C, Mullen KH, Yang C. Treatment decision-making by men with localized prostate cancer: the influence of personal factors. Urol Oncol. 2003;21(2):93–100. - PubMed
2. 1. Feldman-Stewart D, Brundage MD, Van Manen L. A decision aid for men with early stage prostate cancer: theoretical basis and a test by surrogate patients. Health Expect. 2001 Dec;4(4):221–34. - PMC - PubMed
3. 1. Davison BJ, Gleave ME, Goldenberg SL, Degner LF, Hoffart D, Berkowitz J. Assessing information and decision preferences of men with prostate cancer and their partners. Cancer Nurs. 2002 Feb;25(1):42–9. - PubMed
4. 1. Patel HR, Mirsadraee S, Emberton M. The patient's dilemma: prostate cancer treatment choices. J Urol. 2003 Mar;169(3):828–33. doi: 10.1097/01.ju.0000052056.27609.8a. - DOI - PubMed
5. 1. Steginga SK, Occhipinti S, Gardiner RA, Yaxley J, Heathcote P. Making decisions about treatment for localized prostate cancer. BJU Int. 2002 Feb;89(3):255–60. - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3